Head-to-head · WeighScore
Fresh Day Meds vs PepHaūs
By GLP-1 ScorecardUpdated
Score comparison
Fresh Day Meds has the higher recorded score — 84.3/100 to 82.7/100, but only just.
Fresh Day Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fresh Day publishes plan totals that depend on which pharmacy fills the order; renewal every 23 or 83 days needs its own budget. PepHaūs is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Fresh Day Meds review and the PepHaūs review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Fresh Day Meds vs Piper and Green Cap Health vs PepHaūs compare each of them with another graded program, and the list of alternatives to Fresh Day Meds ranks the programs closest to Fresh Day Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Gala Health review covers one graded close to these two, at 82.9/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fresh Day Meds | PepHaūs |
|---|---|---|
| WeighScore | 84.3/100 | 82.7/100 |
| Grade | B | B− |
| Site position | #18 | #25 |
| Semaglutide | $237 three-month plan or $120 one-month, new or transfer (White Label or Drug Crafters fulfillment); renews every 23 or 83 days, confirm selected total | $169 monthly; prepaid plans available (advertised) |
| Tirzepatide | $267 three-month plan or $125 one-month (Black Friday offer to Dec 1; White Label or Drug Crafters fulfillment); renews every 23 or 83 days, confirm selected total | $239 monthly; prepaid plans available (advertised) |
| Coverage | Advertises 49 states plus DC; Arkansas excluded for compounded GLP-1s | Claims all 50 states plus DC; treatment eligibility requires confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Same published total for new and transfer patients
- Care and supplies advertised included
- Confirmed pause can stop future refills
What to consider
- Billing is not calendar-monthly
- Approved orders and future refills have different cancellation rules
- Arkansas GLP-1 access excluded
- Assigned clinician and pharmacy need confirmation
Strengths
- Publishes monthly and prepaid plan amounts
- Names provider and pharmacy partners
What to consider
- Price-lock wording needs reconciling with renewal terms
- Actual supply and longer-plan shipments remain unverified
- Independent license and certification status remain unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.